Ribosomal protein L7a pseudogene 26 (RPL7AP26)

Ribosomal protein L7a pseudogene 26 (RPL7AP26) is classified as a *processed pseudogene* in the human genome, derived from the parent gene encoding ribosomal protein L7a[5][10][12]. Unlike its parent gene, this pseudogene does not encode a functional protein, nor is it believed to have an active biological role. Processed pseudogenes arise from reverse transcription and genomic integration of mRNA transcripts from functional genes, typically lacking regulatory elements and often containing disabling mutations[13]. Although pseudogenes are important genomic elements for the study of genome evolution and potential regulatory functions, RPL7AP26 does not function as a receptor, enzyme, transporter, or any other typical drug target class, and there is no evidence indicating its involvement in disease or drug interactions[13][5][10]. This entry is not a functional protein or validated target; it is a non-coding pseudogene. There is no data supporting its use as a therapeutic target, biomarker, or drug interaction locus[10][13]. The symbol and synonyms are accurate for the corresponding pseudogene, but if a true target is desired, the parent gene/protein is *ribosomal protein L7a* (RPL7A), not the pseudogene[6][9].

Other names

RPL7A_8_496RPL7AP26[2][5][12]